Algo version: 0.98b
INMB is listed at the NASDAQ Exchange
INMB [INMB]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is INMB stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for INmune Bio Inc 10 years ago, but if you had invested on Monday 4th of February 2019 when the price was $7.99, you would have made a loss of $-2.11 per share or -26.41%

Yes, the average daily trading liquidity for INmune Bio Inc is $1.43 million. You should therefore be able to get in and out of your positions relatively fast.

INmune Bio Inc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for INmune Bio Inc to be high [0.85 out of 1]